HB 3717Session 89R
Relating to the establishment of a grant program to fund the United States Food and Drug Administration's drug development trials with ibogaine for the purpose of securing the administration's approval as a medication for treatment of opioid use disorder, co-occurring substance use disorder, and any other neurological or mental health conditions for which ibogaine demonstrates efficacy.
Progress
- Introduced
- In committee
- Passed one chamber Not yet
- Passed legislature Not yet
- Sent to governor Not yet
- Became law Not yet
What this bill would cost
Fiscal notes are prepared by the state’s budget staff and reflect the bill as written at the time.
Legislative history
-
House
Laid on the table subject to call
-
House
Companion considered in lieu of
-
House
Postponed
-
House
Laid out as postponed business
-
House
Postponed
-
House
Laid out as postponed business
-
House
Postponed
-
House
Laid out as postponed business
-
House
Postponed
-
House
Read 2nd time
-
House
Placed on General State Calendar
-
House
Considered in Calendars
-
House
Committee report sent to Calendars
-
House
Committee report distributed
-
House
Comte report filed with Committee Coordinator
-
House
Reported favorably w/o amendment(s)
-
House
Considered in public hearing
-
House
Left pending in committee
-
House
Testimony taken/registration(s) recorded in committee
-
House
Considered in public hearing
-
House
Referred to Public Health
-
House
Read first time
-
House
Filed